ALLO: Cema-cel demonstrates strong MRD clearance, with major clinical and commercial milestones ahead
Significant progress was reported across lead programs, with cema-cel showing strong MRD clearance and commercial planning underway. MRD testing adoption is rising, and the company is positioned ahead of competitors in the consolidation space. Interim data from ALLO-329 and further clinical catalys…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.